Isoniazid molecular structure

Isoniazid

Also known as: Isonex, Solonex, Nydrazid, Rimifon, INH

CAS Number: 54-85-3

Antitubercular (Isonicotinic Acid Hydrazide)

Pharmacopeia Standards

USPBPIPEPJPWHO

Mechanism of Action

Isoniazid is a prodrug activated by the mycobacterial catalase-peroxidase enzyme KatG to a reactive isonicotinoyl radical. This radical forms an adduct with NAD, which inhibits the enoyl-acyl carrier protein reductase InhA in the fatty acid synthase II pathway. Blocking InhA halts mycolic acid biosynthesis, destroying the integrity of the mycobacterial cell wall and producing potent bactericidal activity against actively dividing Mycobacterium tuberculosis.

Technical Specifications

Generic / INN NameIsoniazid
CAS Registry Number54-85-3
Molecular FormulaC6H7N3O
Molecular Weight137.14 g/mol g/mol
Typical Purity99.0% - 101.0% (on dried basis, USP/BP assay)
Storage ConditionsStore in tightly closed, light-resistant containers below 25 degrees C, protected from moisture and light
Shelf Life60 months from date of manufacture when stored as directed
CategoryAnti-Tubercular Agents

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Bulk API for isoniazid tablets (100 mg, 300 mg), dispersible paediatric tablets, oral syrups and injectable solutions. Its dominant use is as the H component of the first-line HRZE four-drug fixed-dose combination (isoniazid, rifampicin, pyrazinamide, ethambutol) and the HR continuation-phase FDC, plus 3HP and 6H TB preventive therapy regimens.

Manufacturers (0+)

View all →
No manufacturers listed yet. Register your company to appear here.